KYTX: Kyverna Therapeutics Company Short-Term Debt
Kyverna Therapeutics (KYTX) specializes in the development and commercialization of medications designed to strengthen the body's defensive functions, with a specific debt metric of 0.00. This chart of share price dynamics helps assess the market trend. The business is implementing green logistics solutions and adhering to research ethics. Currently, Kyverna Therapeutics (KYTX) is actively validating the efficacy of CAR-T methods for combating autoimmune pathologies, backed by robust scientific potential.
Metric breakdowns and analytics for Kyverna Therapeutics, Inc (KYTX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Kyverna Therapeutics|KYTX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Kyverna Therapeutics|KYTX - Company Total Debt|Debt to Book Capitalization Ratio Kyverna Therapeutics, Inc.|KYTX - Company Long-Term Liabilities|Company Current Liabilities Kyverna Therapeutics|Quick Liquidity kyvernatx.com
- net income and valuation multiples indicators:
Initial company analysis:KYTX - Kyverna Therapeutics, Inc.
Short-term debt measures a company's total liabilities with a maturity of up to one year. Investors evaluate this metric to determine the issuer's liquidity and its ability to service current payments. By analyzing the dynamics of short-term borrowed capital, one can identify risks of cash shortages. For Kyverna Therapeutics (KYTX), the absence of revenue makes such obligations critical. Dependence on external research funding increases the importance of controlling the short-term debt load.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB - Company Short-Term Debt|ZBIO - Company Short-Term Debts|IMNM (Immunome, Inc.) - Company Current Liabilities|Short-Term Debt gossamerbio.com (GOSS)|Company Current Liabilities KALV|Company Short-Term Debt SEPN|Company Short-Term Debts PVLA|SVRA - Short-Term Debt|Company Short-Term Debt Rigel Pharmaceuticals RIGL|Company Short-Term Loans and Borrowings ANAB|ATXS - Company Short-Term Debt|ENGN (enGene Holdings Inc) - Company Short-Term Indebtedness|RAPT: Company Short-Term Debts|Aerovate Therapeutics (JBIO) - Company Short-Term Debts|Company Current Liabilities ACRS|TLSA: Company Short-Term Loans and Borrowings|Company Current Liabilities CABA (Cabaletta Bio)|Amount of Current Liabilities VTYX|Company Short-Term Debts THTX (Theratechnologies Inc)|Company Short-Term Loans and Borrowings AVTX|Eledon Pharmaceuticals - Company Short-Term Debts|Short-Term Debt agenusbio.com|Climb Bio (CLYM) - Company Short-Term Debt|zurabio.com - Company Short-Term Loans and Borrowings|ATYR (aTyr) - Company Short-Term Debts|Company Short-Term Debts Adagene Corp|Company Short-Term Debt ImageneBio Inc (IMA)|STTK: Current Liabilities|Company Short-Term Debts EQ (Equillium)|Connect Biopharma Holdings (CNTB) - Short-Term Debt|IMUX: Company Current Liabilities|ATRA - Company Short-Term Debts|IFRX (inflarx.de) - Company Current Liabilities|XFOR: Amount of Current Liabilities|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Celularity Corp (CELU) - Short-Term Debt Volume|Company Short-Term Debts INMB|Company Current Liabilities Barinthus Biotherapeutics Corp BRNS|Company Short-Term Debt Kezar Life Sciences KZR|Short-Term Debt Volume sabbiotherapeutics.com (SABS)|AKTX - Company Short-Term Debt|ENLV - Company Short-Term Debts|QTTB (q32bio.com) - Company Current Liabilities|Short-Term Debt GeoVax Corp (GOVX)|Company Current Liabilities EDSA|IBIO (ibioinc.com) - Amount of Current Liabilities|Company Current Liabilities CARM (Carisma Therapeutics)|XTL Biopharmaceuticals Ltd - Company Short-Term Indebtedness|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB (HCW Biologics, Inc.) - Current Liabilities|Aptevo - Company Short-Term Debts|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|ADTX: Company Short-Term Debts|GRI Bio Inc (GRI) - Company Short-Term Debts|Company Short-Term Debt XORTX|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debt Revelation Biosciences (REVB)|Company Current Liabilities indaptusrx.com INDP|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|AFMD: Company Current Liabilities|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|HOOK: Company Short-Term Debts|IGMS - Short-Term Debt Volume|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD